https://www.selleckchem.com/products/brd7389.html
Cyclophosphamide (CTX) is a first line chemotherapeutic agent, but often limited for its unstable therapeutic effect and serious side effects. Ginsenosides could facilitate the anti-tumor efficiency of CTX, including benefiting therapeutic effect and decreasing side effects. To investigate the potential mechanism of ginsenosides on benefiting the anti-tumor efficiency of CTX. Mammary carcinoma mice were applied to investigate the anti-tumor efficiency and potential mechanism of combinational treatment of ginsenosides and CTX. Therapeuti
Like
Comment
Share
